(13E,15E)-(3S,6S,9R,10R,11S,12S,21S)-3-(3-Hydroxy-benzyl)-6-isopropyl-10,12-dimethoxy-9,11-dimethyl-19-oxa-1,4,7,25-tetraaza-bicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetraone

ID: ALA4090107

PubChem CID: 67978739

Max Phase: Preclinical

Molecular Formula: C34H50N4O8

Molecular Weight: 642.79

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CO[C@@H]1[C@@H](C)[C@@H](OC)/C=C/C=C/CCOC(=O)[C@@H]2CCCN(N2)C(=O)[C@H](Cc2cccc(O)c2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1C

Standard InChI:  InChI=1S/C34H50N4O8/c1-21(2)29-32(41)35-27(20-24-13-11-14-25(39)19-24)33(42)38-17-12-15-26(37-38)34(43)46-18-10-8-7-9-16-28(44-5)22(3)30(45-6)23(4)31(40)36-29/h7-9,11,13-14,16,19,21-23,26-30,37,39H,10,12,15,17-18,20H2,1-6H3,(H,35,41)(H,36,40)/b8-7+,16-9+/t22-,23+,26-,27-,28-,29-,30+/m0/s1

Standard InChI Key:  NEMOPOKMUVPNPN-JJMZVKDLSA-N

Molfile:  

     RDKit          2D

 46 48  0  0  0  0  0  0  0  0999 V2000
    4.2015   -6.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2015   -7.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9068   -7.6230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6121   -7.2186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6121   -6.4013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9068   -5.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9068   -5.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6145   -4.7628    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1991   -4.7628    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6145   -3.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3222   -3.5370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0299   -3.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7376   -3.5370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4453   -3.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1530   -3.5370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8608   -3.9456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5685   -3.5370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8608   -4.7628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1530   -5.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5685   -5.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5685   -5.9886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2762   -4.7628    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2762   -6.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4256   -7.2473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8090   -7.9690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8589   -6.5545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3757   -8.6619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6257   -7.9978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0590   -7.3050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8756   -7.3338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6756   -6.5833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2590   -8.0554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3089   -6.6409    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1256   -6.6697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5090   -7.3914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8257   -8.7483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0757   -8.0842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7591   -9.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3253  -10.0746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7080  -10.7957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5255  -10.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9588  -10.1272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5736   -9.4088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2743  -11.4884    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5616   -2.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9839   -5.1714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  7  9  2  0
 10  8  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  6
 16 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  0
 20 22  1  1
 21 23  1  1
  4 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  1
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  1  1
 30 33  1  0
 33 34  1  0
 34 35  2  0
 32 36  1  0
 32 37  1  0
 21 34  1  0
 27 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 38  1  0
 40 44  1  0
 17 45  1  0
 22 46  1  0
M  END

Associated Targets(Human)

PPIA Tclin Cyclophilin A (674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 642.79Molecular Weight (Monoisotopic): 642.3629AlogP: 2.42#Rotatable Bonds: 5
Polar Surface Area: 155.53Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.46CX Basic pKa: 0.82CX LogP: 2.92CX LogD: 2.91
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.35Np Likeness Score: 1.52

References

1. Steadman VA, Pettit SB, Poullennec KG, Lazarides L, Keats AJ, Dean DK, Stanway SJ, Austin CA, Sanvoisin JA, Watt GM, Fliri HG, Liclican AC, Jin D, Wong MH, Leavitt SA, Lee YJ, Tian Y, Frey CR, Appleby TC, Schmitz U, Jansa P, Mackman RL, Schultz BE..  (2017)  Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.,  60  (3): [PMID:28075591] [10.1021/acs.jmedchem.6b01329]

Source